Funding for this research was provided by:
Eisai Incorporated (MissionAD, MissionAD, MissionAD, MissionAD, MissionAD, MissionAD)
Received: 11 April 2022
Accepted: 11 July 2022
First Online: 27 July 2022
: All studies were conducted in accordance with the Declaration of Helsinki and after approval of the local ethics committees of the participating centers. All participants (or their legal representatives) provided written informed consent prior to recruitment.
: Not applicable.
: SB, NRV, NK, AM, AP, AJ, and AS are employees of Life Molecular Imaging GmbH. SDS was an employee of LMI during the execution of this study. SDS, SK, JK, MK, and MI are employees of Eisai Inc. MG is an employee of Eisai Limited. DS is an employee of Clario. No other potential conflict of interest relevant to this article was reported.